Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

[Prevention and treatment of hepatitis C infected patients on hemodialysis].

Resić H, Masnić F, Vukobrat-Bijedić Z, Kukavica N, Corić A, Bećiragić A, Ajanović S.

Acta Med Croatica. 2012 Jul;66(3):173-8. Croatian.

PMID:
23441531
[PubMed - indexed for MEDLINE]
2.

Pegylated interferon alpha-2a for treatment of chronic HCV infection in hemodialysis patients: a single Saudi center experience.

Alsaran K, Sabry A, Shaheen N.

Int Urol Nephrol. 2011 Sep;43(3):865-73. doi: 10.1007/s11255-010-9756-1. Epub 2010 May 19.

PMID:
20490669
[PubMed - indexed for MEDLINE]
3.

Virological responses of pegylated interferon alpha-2a treatment in hemodialysis patients infected with hepatitis C.

Köse Ş, Senger SS, Ersan G, Çavdar G.

Clin Exp Nephrol. 2013 Feb;17(1):115-9. doi: 10.1007/s10157-012-0663-x. Epub 2012 Jul 20.

PMID:
22814955
[PubMed - indexed for MEDLINE]
4.

Treatment of hepatitis C in hemodialysis patients with pegylated interferon alpha-2a as monotherapy.

Sikole A, Dzekova P, Selja N, Gaseva M, Nikolov IG, Zabzun M, Muharemi S, Asani A, Amitov V, Mena S, Grunevska V, Ivanovski L, Polenakovic M.

Ren Fail. 2007;29(8):961-6.

PMID:
18067041
[PubMed - indexed for MEDLINE]
5.

Long-term follow up of sustained viral response after treatment of hepatitis C with pegylated interferon alpha-2a in hemodialysis patients.

Dzekova P, Asani A, Selim G, Gelev S, Trajceska L, Amitov V, Selja N, Zabzun M, Mena S, Gaseva M, Sikole A.

Int J Artif Organs. 2009 Mar;32(3):180-4.

PMID:
19440994
[PubMed - indexed for MEDLINE]
6.

Superiority of standard interferon-alpha2b compared to pegylated interferon-alpha2b (12 kDa) in a hemodialysis patient with chronic hepatitis C?

Potthoff A, Wiegand J, Lüth JB, Wedemeyer H, Manns MP, Tillmann HL.

Clin Nephrol. 2005 Mar;63(3):232-5.

PMID:
15786827
[PubMed - indexed for MEDLINE]
7.

Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C.

Liu CH, Liang CC, Liu CJ, Lin JW, Chen SI, Hung PH, Tsai HB, Lai MY, Chen PJ, Chen DS, Kao JH.

Clin Infect Dis. 2010 Sep 1;51(5):541-9. doi: 10.1086/655682.

PMID:
20645865
[PubMed - indexed for MEDLINE]
Free Article
8.

GB virus C (GBV-C) infection in patients with chronic hepatitis C. Influence on liver disease and on hepatitis virus behaviour: effect of interferon alfa therapy.

Pawlotsky JM, Roudot-Thoraval F, Muerhoff AS, Pellerin M, Germanidis G, Desai SM, Bastie A, Darthuy F, Rémiré J, Zafrani ES, Soussy CJ, Mushahwar IK, Dhumeaux D.

J Med Virol. 1998 Jan;54(1):26-37.

PMID:
9443106
[PubMed - indexed for MEDLINE]
9.

Clinical and laboratory characteristics of acute hepatitis C in patients with end-stage renal disease on hemodialysis.

Lemos LB, Perez RM, Matos CA, Silva IS, Silva AE, Ferraz ML.

J Clin Gastroenterol. 2008 Feb;42(2):208-11. doi: 10.1097/MCG.0b013e31802dc57f.

PMID:
18209594
[PubMed - indexed for MEDLINE]
10.

Efficacy and tolerability of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C.

Kokoglu OF, Uçmak H, Hosoglu S, Cetinkaya A, Kantarceken B, Buyukbese MA, Isik IO.

J Gastroenterol Hepatol. 2006 Mar;21(3):575-80.

PMID:
16638102
[PubMed - indexed for MEDLINE]
11.

HCV response in patients with end stage renal disease treated with combination pegylated interferon alpha-2a and ribavirin.

Hakim W, Sheikh S, Inayat I, Caldwell C, Smith D, Lorber M, Friedman A, Jain D, Bia M, Formica R, Mehal W.

J Clin Gastroenterol. 2009 May-Jun;43(5):477-81. doi: 10.1097/MCG.0b013e318180803a.

PMID:
19142165
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.

Mousa DH, Abdalla AH, Al-Shoail G, Al-Sulaiman MH, Al-Hawas FA, Al-Khader AA.

Transplant Proc. 2004 Jul-Aug;36(6):1831-4.

PMID:
15350490
[PubMed - indexed for MEDLINE]
13.

Acute hepatitis C in patients receiving hemodialysis.

Griveas I, Germanidis G, Visvardis G, Morice Y, Perelson AS, Pawlotsky JM, Papadopoulou D.

Ren Fail. 2007;29(6):731-6.

PMID:
17763169
[PubMed - indexed for MEDLINE]
14.

Long-term efficacy of pegylated interferon alpha-2a in HCV-positive hemodialysis patients.

Ucmak H, Kokoglu OF, Hosoglu S, Dogan E, Sayarlioglu H, Kuzhan N, Isik IO.

Ren Fail. 2008;30(2):227-32. doi: 10.1080/08860220701813368. Erratum in: Ren Fail. 2008;30(3):343. Ucmaky, Hasan [corrected to Ucmak, Hasan]; Kokoglu, Omer Faruk [corrected to Kokoglu, Omer Faruk].

PMID:
18300126
[PubMed - indexed for MEDLINE]
15.

Predictive factors for sustained response to interferon treatment in patients with chronic hepatitis C: a randomized, open, and multi-center controlled trial.

Xie Y, Xu DZ, Lu ZM, Luo KX, Jia JD, Wang YM, Zhao GZ, Zhang SL, Zhang DZ.

Hepatobiliary Pancreat Dis Int. 2005 May;4(2):213-9.

PMID:
15908318
[PubMed - indexed for MEDLINE]
Free Article
16.

[Infection by hepatitis C virus in patients on hemodialysis: prevalence and risk factors].

Leão JR, Pace FH, Chebli JM.

Arq Gastroenterol. 2010 Jan-Mar;47(1):28-34. Portuguese.

PMID:
20520972
[PubMed - indexed for MEDLINE]
Free Article
17.

Significance of anti-hepatitis C virus core IgM antibodies in patients with chronic hepatitis C.

Pawlotsky JM, Darthuy F, Rémiré J, Pellet C, Udin L, Stuyver L, Roudot-Thoraval F, Duvoux C, Douvin C, Mallat A, et al.

J Med Virol. 1995 Nov;47(3):285-91.

PMID:
8551282
[PubMed - indexed for MEDLINE]
18.

Impaired response to alpha interferon in patients with an inapparent hepatitis B and hepatitis C virus coinfection.

Zignego AL, Fontana R, Puliti S, Barbagli S, Monti M, Careccia G, Giannelli F, Giannini C, Buzzelli G, Brunetto MR, Bonino F, Gentilini P.

Arch Virol. 1997;142(3):535-44.

PMID:
9349299
[PubMed - indexed for MEDLINE]
19.

Efficacy and safety of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C.

Ayaz C, Celen MK, Yuce UN, Geyik MF.

World J Gastroenterol. 2008 Jan 14;14(2):255-9.

PMID:
18186564
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

[HCV RNA clearance after treatment with interferon-alpha in chronic hemodialysis patients with or without coinfection by HGV/HGBV-C].

Rostaing L, Izopet J, Moussion F, Alric L, Verdier D, That HT, Duffaut M, Durand D, Puel J, Suc JM.

Nephrologie. 1997;18(7):281-6. French.

PMID:
9496568
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk